Role of mast cells in allergic and non-allergic immune responses: Comparison of human and murine data

Nature Reviews Immunology

Volumn 7, Issue 2, 2007, Pages 93-104

  Bischoff, Stephan C ^a  

^a UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CROMOGLYCATE DISODIUM; CYTOKINE; FC RECEPTOR; GROWTH FACTOR; IMATINIB; IMMUNOGLOBULIN E; PROTEIN TYROSINE KINASE INHIBITOR; TOLL LIKE RECEPTOR;

ALLERGIC ASTHMA; ALLERGIC DISEASE; ALLERGIC REACTION; ALLERGIC RHINITIS; ALLERGY; CELL TYPE; CONJUNCTIVITIS; DELAYED HYPERSENSITIVITY; GASTROENTERITIS; GASTROINTESTINAL STROMAL TUMOR; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; MAST CELL; MASTOCYTOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; HUMANS; HYPERSENSITIVITY; IMMUNITY, CELLULAR; MAST CELLS; MICE; RATS; RECEPTORS, IGE;

EID: 33846581108     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2018     Document Type: Review

References (146)

1. Gurish, M. F. & Austen, K. F. The diverse roles of mast cells. J. Exp. Med. 194, 1-5 (2001).
2. Bradding, P., Walls, A. F. & Holgate, S. T. The role of the mast cell in the pathophysiology of asthma. J. Allergy Clin. Immunol. 117, 1277-1284 (2006).
3. Leung, D. Y., Boguniewicz, M., Howell, M. D., Nomura, I. & Hamid, Q. A. New insights into atopic dermatitis. J. Clin. Invest. 113, 651-657 (2004).
4. Bischoff, S. C. & Crowe, S. E. Gastrointestinal food allergy: new insights into pathophysiology and clinical perspectives. Gastroenterology 128, 1089-1113 (2005).
5. Bischoff, S. C. in Mast cells and basophils (eds Marone, G., Lichtenstein, L. M. & Galli, S. J.) 541-565 (Academic Press, San Diego, 2000).
6. Vliagoftis, H. & Befus, A. D. Mast cells at mucosal frontiers. Curr. Mol. Med. 5, 573-589 (2005).
7. Galli, S. J., Nakae, S. & Tsai, M. Mast cells in the development of adaptive immune responses. Nature Immunol. 6, 135-142 (2005).
8. Lu, L. F. et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442, 997-1002 (2006). This study establishes for the first time that mast cells are essential in CD4+CD25+FOXP3+ regulatory T-cell-dependent peripheral tolerance in mice, and that IL-9 is the functional link by which activated T cells recruit and activate mast cells to mediate regional immune suppression.
9. Lee, D. M. et al. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297, 1689-1692 (2002).
10. Theoharides, T. C. & Cochrane, D. E. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J. Neuroimmunol. 146, 1-12 (2004).
11. Barbara, G. et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 126, 693-702 (2004). This paper shows for the first time that human mast cells form functional synapses with nerve endings in vivo and that such synapses mediate pain, which is one of the main symptoms of irritable bowel syndrome, to the central nervous system.
12. Marshall, J. S. Mast cell responses to pathogens. Nature Rev. Immunol. 4, 787-799 (2004).
13. Malaviya, R. & Georges, A. Regulation of mast cell-mediated innate immunity during early response to bacterial infection. Clin. Rev. Allergy Immunol. 22, 189-204 (2002).
14. Maurer, M. et al. What is the physiological function of mast cells? Exp. Dermatol. 12, 886-910 (2003).
15. Maurer, M. et al. Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature 432, 512-516 (2004). This study, although carried out in the murine system, further establishes mast cells as part of the innate immune defence mechanisms that can be activated not only by microorganisms but also by endogenous factors such as endothelin.
16. Garfield, R. E., Irani, A. M., Schwartz, L. B., Bytautiene, E. & Romero, R. Structural and functional comparison of mast cells in the pregnant versus nonpregnant human uterus. Am. J. Obstet. Gynecol. 194, 261-267 (2006).
17. Cooper, P. H. & Stanworth, D. R. Isolation of rat peritoneal mast cells in high yield and purity. Methods Cell. Biol. 14, 365-378 (1976).
18. Enerback, L. & Wingren, U. Histamine content of peritoneal and tissue mast cells of growing rats. Histochemistry 66, 113-124 (1980).
19. Bischoff, S. C. et al. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology 28, 1-13 (1996).
20. Abonia, J. P. et al. Constitutive homing of mast cell progenitors to the intestine depends on autologous expression of the chemokine receptor CXCR2. Blood 105, 4308-4313 (2005).
21. Schernthaner, G. H. et al. Detection of differentiation-and activation-linked cell surface antigens on cultured mast cell progenitors. Allergy 60, 1248-1255 (2005).
22. Dahl, C., Hoffmann, H. J., Saito, H. & Schiotz, P. O. Human mast cells express receptors for IL-3, IL-5 and GM-CSF; a partial map of receptors on human mast cells cultured in vitro. Allergy 59, 1087-1096 (2004).
23. Rennick, D., Hunte, B., Holland, G. & Thompson-Snipes, L. Cofactors are essential for stem cell factor-dependent growth and maturation of mast cell progenitors: comparative effects of interleukin-3 (IL-3), IL-4, IL-10, and fibroblasts. Blood 85, 57-65 (1995).
24. Thienemann, F., Henz, B. M. & Babina, M. Regulation of mast cell characteristics by cytokines: divergent effects of interleukin-4 on immature mast cell lines versus mature human skin mast cells. Arch. Dermatol. Res. 296, 134-138 (2004).
25. Bischoff, S. C., Sellge, G., Schwengberg, S., Lorentz, A. & Manns, M. P. Stem cell factor-dependent survival, proliferation and enhanced releasability of purified mature mast cells isolated from human intestinal tissue. Int. Arch. Allergy Immunol. 118, 104-107 (1999).
26. Sellge, G. & Bischoff, S. C. Isolation, culture, and characterization of intestinal mast cells. Methods Mol. Biol. 315, 123-138 (2006). This paper summarizes our current knowledge of basic techniques for the isolation of human mast cells from mucosal tissues.
27. MacDonald, A. J. et al. Rat bone marrow-derived mast cells co-cultured with 3T3 fibroblasts in the absence of T-cell derived cytokines require stem cell factor for their survival and maintain their mucosal mast cell-like phenotype. Immunology 88, 375-383 (1996).
28. Galli, S. J. et al. Mast cells as 'tunable' effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 23, 749-786 (2005).
29. Kirshenbaum, A. S. et al. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcεRI or FcγRI. Leuk. Res. 27, 677-682 (2003).
30. + bone marrow progenitor cells. J. Immunol. 146, 1410-1415 (1991).
31. Mitsui, H. et al. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc. Natl Acad. Sci. USA 90, 735-739 (1993). This paper established SCF as the most relevant human mast-cell growth factor.
32. Toru, H. et al. Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation. Blood 91, 187-195 (1998).
33. Denburg, J. A. Basophil and mast cell lineages in vitro and in vivo. Blood 79, 846-860 (1992).
34. Agis, H. et al. Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes. Immunology 87, 535-543 (1996).
35. Nakajima, T. et al. Gene expression screening of human mast cells and eosinophils using high-density oligonucleotide probe arrays: abundant expression of major basic protein in mast cells. Blood 98, 1127-1134 (2001).
36. Foster, B., Schwartz, L. B., Devouassoux, G., Metcalfe, D. D. & Prussin, C. Characterization of mast cell tryptase-expressing peripheral blood cells as basophils. J. Allergy Clin. Immunol. 109, 287-293 (2002).
37. Huang, R. et al. Expression of a mast cell tryptase in the human monocytic cell lines U-937 and Mono Mac 6. Scand. J. Immunol. 38, 359-367 (1993).
38. Ito, T. et al. Mast cells acquire monocyte-specific gene expression and monocyte-like morphology by overproduction of PU.1. J. Immunol. 174, 376-383 (2005).
39. Kempuraj, D. et al. Characterization of mast cell-committed progenitors present in human umbilical cord blood. Blood 93, 3338-3346 (1999).
40. Kocabas, C. N., Yavuz, A. S., Lipsky, P. E., Metcalfe, D. D. & Akin, C. Analysis of the lineage relationship between mast cells and basophils using the c-kit D816V mutation as a biologic signature. J. Allergy Clin. Immunol. 115, 1155-1161 (2005).
41. Razin, E. et al. Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan. J. Immunol. 132, 1479-1486 (1984).
42. Valent, P. et al. Failure to detect IL-3-binding sites on human mast cells. J. Immunol. 145, 3432-3437 (1990).
43. Gebhardt, T. et al. Cultured human intestinal mast cells express functional IL-3 receptors and respond to IL-3 by enhancing growth and IgE receptor-dependent mediator release. Eur. J. Immunol. 32, 2308-2316 (2002).
44. Kurimoto, Y., De Weck, A. L. & Dahinden, C. A. The effect of interleukin 3 upon IgE-dependent and IgEindependent basophil degranulation and leukotriene generation. Eur. J. Immunol. 21, 361-368 (1991).
45. Boyce, J. A. Eicosanoid mediators of mast cells: receptors, regulation of synthesis, and pathobiologic implications. Chem. Immunol. Allergy 87, 59-79 (2005).
46. Weller, C. L. et al. Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors. J. Exp. Med. 201, 1961-1971 (2005).
47. Lorentz, A., Schwengberg, S., Mierke, C., Manns, M. P. & Bischoff, S. C. Human intestinal mast cells produce IL-5 in vitro upon IgE receptor cross-linking and in vivo in the course of intestinal inflammatory disease. Eur. J. Immunol. 29, 1496-1503 (1999).
48. Lorentz, A., Schwengberg, S., Sellge, G., Manns, M. P. & Bischoff, S. C. Human intestinal mast cells are capable of producing different cytokine profiles: role of IgE receptor cross-linking and IL-4. J. Immunol. 164, 43-48 (2000).
49. Schechter, N. M., Pereira, P. J. B. & Strobl, S. in Mast Cells and Basophils (eds Marone, G., Lichtenstein, L.M. Galli, S.J.) 275-290 (Academic Press, San Diego, 2000).
50. Hallgren, J. & Pejler, G. Biology of mast cell tryptase. An inflammatory mediator. FEBS J. 273, 1871-1895 (2006).
51. Miller, H. R. & Pemberton, A. D. Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut. Immunology 105, 375-390 (2002).
52. H2-skewed diseases.
53. Mierke, C. T. et al. Human endothelial cells regulate survival and proliferation of human mast cells. J. Exp. Med. 192, 801-811 (2000).
54. Nakajima, T. et al. Marked increase in CC chemokine gene expression in both human and mouse mast cell transcriptomes following Fcε receptor I cross-linking: an interspecies comparison. Blood 100, 3861-3868 (2002). References 35 and 54 are a unique and valuable source of information about differences in gene expression between human and murine mast cells, as well as between human mast cells and eosinophils or basophils.
55. Gelfand, E. W. Pro: mice are a good model of human airway disease. Am. J. Respir. Crit. Care Med. 166, 5-6 (2002).
56. Persson, C. G. Con: mice are not a good model of human airway disease. Am. J. Respir. Crit. Care Med. 166, 6-7 (2002).
57. Hamelmann, E. et al. Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization. Am. J. Respir. Crit. Care Med. 155, 819-825 (1997).
58. Leckie, M. J. et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyperresponsiveness, and the late asthmatic response. Lancet 356, 2144-2148 (2000).
59. Saito, H. Mast cell-specific genes - new drug targets/pathogenesis. Chem. Immunol. Allergy 87, 198-212 (2005).
60. Kitamura, Y., Kasugai, T., Arizono, N. & Matsuda, H. Development of mast cells and basophils: processes and regulation mechanisms. Am. J. Med. Sci. 306, 185-191 (1993).
61. Bischoff, S. C., de Weck, A. L. & Dahinden, C. A. Interleukin 3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a. Proc. Natl Acad. Sci. USA 87, 6813-6817 (1990).
62. Seder, R. A. et al. Production of interleukin-4 and other cytokines following stimulation of mast cell lines and in vivo mast cells/basophils. Int. Arch. Allergy Appl. Immunol. 94, 137-140 (1991).
63. Brunner, T., Heusser, C. H. & Dahinden, C. A. Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J. Exp. Med. 177, 605-611 (1993).
64. Min, B. et al. Basophils produce IL-4 and accumulate in tissues after infection with a Th2-inducing parasite. J. Exp. Med. 200, 507-517 (2004).
65. Bradding, P. et al. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J. Immunol. 151, 3853-3865 (1993).
66. Bischoff, S. C. et al. Mast cells are an important cellular source of tumour necrosis factor α in human intestinal tissue. Gut 44, 643-652 (1999).
67. Nakae, S. et al. Mast cells enhance T cell activation: Importance of mast cell-derived TNF. Proc. Natl Acad. Sci. USA 102, 6467-6472 (2005).
68. Rogler, G. et al. Isolation and phenotypic characterization of colonic macrophages. Clin. Exp. Immunol. 112, 205-215 (1998).
69. Kinet, J. P. The high-affinity IgE receptor (FcεRI): From physiology to pathology. Annu. Rev. Immunol. 17, 931-972 (1999).
70. Rivera, J. & Gilfillan, A. M. Molecular regulation of mast cell activation. J. Allergy Clin. Immunol. 117, 1214-1225 (2006).
71. Gilfillan, A. M. & Tkaczyk, C. Integrated signalling pathways for mast cell activation. Nature Rev. Immunol. 6, 218-230 (2006).
72. Lorentz, A., Klopp, I., Gebhardt, T., Manns, M. P. & Bischoff, S. C. Role of activator protein-1, nuclear factor-κB and nuclear factor of activated T-cells in IgE receptor-mediated cytokine expression in mature human mast cells. J. Allergy Clin. Immunol. 111, 1062-1068 (2003).
73. Kawakami, T. & Galli, S. J. Regulation of mast cell and basophil function and survival by IgE. Nature Rev. Immunol. 2, 773-786 (2002).
74. Kalesnikoff, J. et al. Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity 14, 801-811 (2001). This paper shows for the first time that mast cells can be activated by soluble monomeric IgE in the absence of antigen. This finding has implications for understanding the mechanisms of allergen-independent mast-cell activation and perpetuation of allergic symptoms in the absence of allergen.
75. Matsuda, K. et al. Monomeric IgE enhances human mast cell chemokine production: IL-4 augments and dexamethasone suppresses the response. J. Allergy Clin. Immunol. 116, 1357-1363 (2005).
76. Cruse, G. et al. Activation of human lung mast cells by monomeric immunoglobulin E. Eur. Respir. J. 25, 858-863 (2005).
77. Redegeld, F. A. et al. Immunoglobulin-free light chains elicit immediate hypersensitivity-like responses. Nature Med. 8, 694-701 (2002).
78. Kraneveld, A. D. et al. Elicitation of allergic asthma by immunoglobulin free light chains. Proc. Natl Acad. Sci. USA 102, 1578-1583 (2005).
79. Lorentz, A., Schuppan, D., Gebert, A., Manns, M. P. & Bischoff, S. C. Regulatory effects of stem cell factor and interleukin-4 on adhesion of human mast cells to extracellular matrix proteins. Blood 99, 966-972 (2002).
80. Bischoff, S. C. & Dahinden, C. A. c-kit ligand: a unique potentiator of mediator release by human lung mast cells. J. Exp. Med. 175, 237-244 (1992). In this paper, the multiple regulatory functions of SCF in fully mature human tissue mast cells are identified.
81. Undem, B. J., Lichtenstein, L. M., Hubbard, W. C., Meeker, S. & Ellis, J. L. Recombinant stem cell factor-induced mast cell activation and smooth muscle contraction in human bronchi. Am. J. Respir. Cell. Mol. Biol. 11, 646-650 (1994).
82. H2 cytokines on SCF-dependent human mast cell production in vitro: correlation with apoptosis and Kit expression. Blood 105, 592-599 (2005).
83. H2 cytokine generation is reversible and associated with increased activity of ERK1/2 and c-Fos. J. Immunol. 174, 6751-6756 (2005).
84. Okayama, Y., Hagaman, D. D. & Metcalfe, D. D. A comparison of mediators released or generated by IFN-γ-treated human mast cells following aggregation of FcγRI or FcεRI. J. Immunol. 166, 4705-4712 (2001).
85. el-Lati, S. G., Dahinden, C. A & Church, M. K. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells. J. Invest. Dermatol. 102, 803-806 (1994).
86. Guhl, S., Lee, H. H., Babina, M., Henz, B. M. & Zuberbier, T. Evidence for a restricted rather than generalized stimulatory response of skin-derived human mast cells to substance P. J. Neuroimmunol. 163, 92-101 (2005).
87. Bischoff, S. C. et al. Substance P and other neuropeptides do not induce mediator release in isolated human intestinal mast cells. Neurogastroenterol. Motil. 16, 185-193 (2004).
88. van der Kleij, H. P. et al. Functional expression of neurokinin 1 receptors on mast cells induced by IL-4 and stem cell factor. J. Immunol. 171, 2074-2079 (2003).
89. Miyazaki, D. et al. Macrophage inflammatory protein-1α as a costimulatory signal for mast cell-mediated immediate hypersensitivity reactions. J. Clin. Invest. 115, 434-442 (2005).
90. Varadaradjalou, S, et al. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur. J. Immunol. 33, 899-906 (2003).
91. Iida, M. et al. Selective down-regulation of high-affinity IgE receptor (FcεRI) α-chain messenger RNA among transcriptome in cord blood-derived versus adult peripheral blood-derived cultured human mast cells. Blood 97, 1016-1022 (2001).
92. Inomata, N., Tomita, H., Ikezawa, Z. & Saito, H. Differential gene expression profile between cord blood progenitor-derived and adult progenitor-derived human mast cells. Immunol. Lett. 98, 265-271 (2005).
93. Malbec, O., Attal, J. P., Fridman, W. H. & Daeron, M. Negative regulation of mast cell proliferation by FcγRIIB. Mol. Immunol. 38, 1295-1299 (2002).
94. Abramson, J., Xu, R. & Pecht, I. An unusual inhibitory receptor-the mast cell function-associated antigen (MAFA). Mol. Immunol. 38, 1307-1313 (2002).
95. Luskova, P. & Draber, P. Modulation of the Fcε receptor I signaling by tyrosine kinase inhibitors: search for therapeutic targets of inflammatory and allergy diseases. Curr. Pharm. Des. 10, 1727-1737 (2004).
96. Bachelet, I., Munitz, A., Moretta, A., Moretta, L. & Levi-Schaffer, F. The inhibitory receptor IRp60 (CD300a) is expressed and functional on human mast cells. J. Immunol. 175, 7989-7995 (2005).
97. Sloane, D. E. et al. Leukocyte immunoglobulin-like receptors: novel innate receptors for human basophil activation and inhibition. Blood 104, 2832-2839 (2004).
98. Brown, D., Trowsdale, J. & Allen, R. The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens 64, 215-225 (2004).
99. Gebhardt, T. et al. Growth, phenotype, and function of human intestinal mast cells are tightly regulated by transforming growth factor β1. Gut 54, 928-934 (2005).
100. Royer, B. et al. Inhibition of IgE-induced activation of human mast cells by IL-10. Clin. Exp. Allergy 31, 694-704 (2001).
101. Cherwinski, H. M. et al. The CD200 receptor is a novel and potent regulator of murine and human mast cell function. J. Immunol. 174, 1348-1356 (2005).
102. Zhang, S., Cherwinski, H., Sedgwick, J. D. & Phillips, J. H. Molecular mechanisms of CD200 inhibition of mast cell activation. J. Immunol. 173, 6786-6793 (2004).
103. Zhu, M., Liu, Y., Koonpaew, S., Granillo, O. & Zhang, W. Positive and negative regulation of FcεRI-mediated signaling by the adaptor protein LAB/NTAL. J. Exp. Med. 200, 991-1000 (2004).
104. Tam, S. Y. et al. RabGEF1 is a negative regulator of mast cell activation and skin inflammation. Nature Immunol. 5, 844-852 (2004).
105. Hjertson, M. et al. Retinoic acid inhibits in vitro development of mast cells but has no marked effect on mature human skin tryptase- and chymase-positive mast cells. J. Invest. Dermatol. 120, 239-245 (2003).
106. Ishida, S., Kinoshitam, T., Sugawaram, N., Yamashita, T. & Koike, K. Serum inhibitors for human mast cell growth: possible role of retinol. Allergy 58, 1044-1052 (2003).
107. Gebhardt, T. et al. β2-Adrenoceptor-mediated suppression of human intestinal mast cell functions is caused by disruption of filamentous actin dynamics. Eur. J. Immunol. 35, 1124-1132 (2005).
108. Kraft, S. et al. Anti-CD63 antibodies suppress IgE-dependent allergic reactions in vitro and in vivo. J. Exp. Med. 201, 385-396 (2005).
109. Zhu, D. et al. A chimeric human-cat fusion protein blocks cat-induced allergy. Nature Med. 11, 446-449 (2005). This paper shows for the first time that novel mechanisms of mast-cell inhibition developed in vitro are applicable in vivo and offer new strategies for the treatment of allergic diseases.
110. Kinet, J. P. A new strategy to counter allergy. N. Engl. J. Med. 353, 310-312 (2005).
111. Pardanani, A. et al. Imatinib for systemic mast cell disease. Lancet 362, 535-536 (2003).
112. Berlin, A. A. & Lukacs, N. W. Treatment of cockroach allergen asthma model with imatinib attenuates airway responses. Am. J. Respir. Crit. Care Med. 171, 35-39 (2005).
113. Dietz, A. B. et al. Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivo. Blood 104, 1094-1099 (2004).
114. Norris, A. A. Pharmacology of sodium cromoglycate. Clin. Exp. Allergy 26 (Suppl. 4), 5-7 (1996).
115. Edwards, A. M. Oral sodium cromoglycate: its use in the management of food allergy. Clin. Exp. Allergy 25 (Suppl. 1), 31-33 (1995).
116. Cole, Z. A., Clough, G. F. & Church, M. K. Inhibition by glucocorticoids of the mast cell-dependent weal and flare response in human skin in vivo. Br. J. Pharmacol. 132, 286-292 (2001).
117. Marone, G., Triggiani, M., Genovese, A. & Paulis, A. D. Role of human mast cells and basophils in bronchial asthma. Adv. Immunol. 88, 97-160 (2005).
118. Wood, J. D. Enteric neuroimmunophysiology and pathophysiology. Gastroenterology 127, 635-657 (2004).
119. Krishna, M. T. et al. Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced latephase airway obstruction in asthma. J. Allergy Clin. Immunol. 107, 1039-1045 (2001).
120. Furuta, G. T. et al. Mast cell-dependent tumor necrosis factor α production participates in allergic gastric inflammation in mice. Gastroenterology 113, 1560-1569 (1997).
121. Biedermann, T. et al. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J. Exp. Med. 192, 1441-1452 (2000).
122. Malaviya, R., Navara, C. & Uckun, F. M. Role of Janus kinase 3 in mast cell-mediated innate immunity against gram-negative bacteria. Immunity 15, 313-321 (2001).
123. Dahlen, S. E. & Kumlin, M. Monitoring mast cell activation by prostaglandin D2 in vivo. Thorax 59, 453-455 (2004).
124. Brightling, C. E. et al. Mast cell infiltration of airway smooth muscle in asthma. N. Engl. J. Med. 346, 1699-1705 (2002). This paper establishes mast cells as crucial cells involved not only in mucosal-tissue responses, but also in smooth-muscle responses in human asthmatic individuals.
125. Oguma, T. et al. Role of prostanoid DP receptor variants in susceptibility to asthma. N. Engl. J. Med. 351, 1752-1763 (2004).
126. Luster, A. D. & Tager, A. M. T-cell trafficking in asthma: lipid mediators grease the way. Nature Rev. Immunol. 4, 711-724 (2004).
127. Kashiwakura, J., Yokoi, H., Saito, H. & Okayama, Y. T cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells. J. Immunol. 173, 5247-5257 (2004).
128. Mukai, K. et al. Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells. Immunity 23, 191-202 (2005). This paper defines and separates the functions of mast cells and basophils in vivo in the pathogenesis of allergic inflammation.
129. Al-Muhsen, S. Z., Shablovsky, G., Olivenstein, R., Mazer, B. & Hamid, Q. The expression of stem cell factor and c-kit receptor in human asthmatic airways. Clin. Exp. Allergy 34, 911-916 (2004).
130. Macdonald, T. T. & Monteleone, G. Immunity, inflammation, and allergy in the gut. Science 307, 1920-1925 (2005).
131. Moriarty, D., Goldhill, J., Selve, N., O'Donoghue, D. P. & Baird, A. W. Human colonic anti-secretory activity of the potent NK(1) antagonist, SR140333: assessment of potential anti-diarrhoeal activity in food allergy and inflammatory bowel disease. Br. J. Pharmacol. 133, 1346-1354 (2001).
132. Finkelman, F. D. et al. Interleukin-4- and interleukin-13-mediated host protection against intestinal nematode parasites. Immunol. Rev. 201, 139-155 (2004).
133. Schramm, G. et al. Molecular characterization of an interleukin-4-inducing factor from Schistosoma mansoni eggs. J. Biol. Chem. 278, 18384-18392 (2003).
134. Helmby, H. & Grencis, R. K. IL-18 regulates intestinal mastocytosis and Th2 cytokine production independently of IFN-γ during Trichinella spiralis infection. J. Immunol. 169, 2553-2560 (2002).
135. Boyce, J. A. Mast cells: beyond IgE. J. Allergy Clin. Immunol. 111, 24-32 (2003).
136. + T-cell recruitment. Blood 106, 978-987 (2005).
137. Kulka, M., Alexopoulou, L., Flavell, R. A. & Metcalfe, D. D. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J. Allergy Clin. Immunol. 114, 174-182 (2004).
138. Woolley, D. E. The mast cell in inflammatory arthritis. N. Engl. J. Med. 348, 1709-1711 (2003).
139. Valent, P. et al. New aspects in thrombosis research: possible role of mast cells as profibrinolytic and antithrombotic cells. Thromb. Haemost. 87, 786-790 (2002).
140. Lindstedt, K. A. & Kovanen, P. T. Mast cells in vulnerable coronary plaques: potential mechanisms linking mast cell activation to plaque erosion and rupture. Curr. Opin. Lipidol. 15, 567-573 (2004).
141. Silver, R. B. et al. Mast cells: a unique source of renin. Proc. Natl Acad. Sci. USA 101, 13607-13612 (2004).
142. Zappulla, J. P., Arock, M., Mars, L. T. & Liblau, R. S. Mast cells: new targets for multiple sclerosis therapy? J. Neuroimmunol. 131, 5-20 (2002).
143. Theoharides, T. C., Donelan, J., Kandere-Grzybowska, K. & Konstantinidou, A. The role of mast cells in migraine pathophysiology. Brain Res. Rev. 49, 65-76 (2005).
144. Kashtan, N. & Alon, U. Spontaneous evolution of modularity and network motifs. Proc. Natl Acad. Sci. USA. 102, 13773-13778 (2005).
145. Jin, F. et al. A pooling-deconvolution strategy for biological network elucidation. Nature Methods 3, 183-189 (2006).
146. Theoharides, T. C. & Bielory, L. mast cells and mast cell mediators as targets of dietary supplements. Ann. Allergy Asthma Immunol. 93, S24-S34 (2004).